1. Home
  2. GNPX vs IVDA Comparison

GNPX vs IVDA Comparison

Compare GNPX & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$2.32

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.78

Market Cap

5.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
IVDA
Founded
2009
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
5.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GNPX
IVDA
Price
$2.32
$0.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
169.2K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,395,926.00
Revenue This Year
N/A
$340.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.56
52 Week Low
$1.71
$0.61
52 Week High
$55.00
$4.27

Technical Indicators

Market Signals
Indicator
GNPX
IVDA
Relative Strength Index (RSI) 45.18 38.59
Support Level $2.63 $0.82
Resistance Level $3.04 $1.12
Average True Range (ATR) 0.43 0.09
MACD 0.04 -0.02
Stochastic Oscillator 31.28 10.26

Price Performance

Historical Comparison
GNPX
IVDA

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

Share on Social Networks: